These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7512199)

  • 1. Benzyl acetate: from mutagenic carcinogen to non-mutagenic non-carcinogenic in 7 years?
    Ashby J
    Mutat Res; 1994 Apr; 306(1):107-9. PubMed ID: 7512199
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspective on the usefulness of the mouse lymphoma assay as an indicator of a genotoxic carcinogen: ten compounds which are positive in the mouse lymphoma assay but are not genotoxic carcinogens.
    Caldwell J
    Teratog Carcinog Mutagen; 1993; 13(4):185-90. PubMed ID: 7903486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzyl acetate.
    IARC Monogr Eval Carcinog Risks Hum; 1999; 71 Pt 3(PT 3):1255-64. PubMed ID: 10476393
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploring relationships between mutagenic and carcinogenic potencies.
    Piegorsch WW; Hoel DG
    Mutat Res; 1988 Sep; 196(2):161-75. PubMed ID: 3419441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagens that are not carcinogens: faulty theory or faulty tests?
    Zeiger E
    Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
    Hayward JJ; Shane BS; Tindall KR; Cunningham ML
    Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals.
    Gold LS; Slone TH; Stern BR; Bernstein L
    Mutat Res; 1993 Mar; 286(1):75-100. PubMed ID: 7678909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinction of mutagenic carcinogens from a mutagenic noncarcinogen in the big blue transgenic mouse.
    Cunningham ML; Hayward JJ; Shane BS; Tindall KR
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):683-6. PubMed ID: 8781405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens.
    French J; Storer RD; Donehower LA
    Toxicol Pathol; 2001; 29 Suppl():24-9. PubMed ID: 11695559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic toxicology: current status of methods of carcinogen identification.
    Tennant RW; Zeiger E
    Environ Health Perspect; 1993 Apr; 100():307-15. PubMed ID: 8354178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mutagenic Activity of Four Aminoazo Compounds with Different Carcinogenicity for Rat Liver in the Ames Test].
    Frolova TS; Sinitsyna OI; Kaledin VI
    Biofizika; 2015; 60(5):990-4. PubMed ID: 26591610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential halogenated industrial carcinogenic and mutagenic chemicals. IV. Halogenated aryl derivatives.
    Fishbein L
    Sci Total Environ; 1979 Apr; 11(3):259-78. PubMed ID: 375389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of potential carcinogenic dyes and intermediates on the basis of their genotoxicity].
    Barański B; Przybojewska B; Spiechowicz E; Wyszyńska K; Zimnicki J
    Med Pr; 1992; 43(6):469-77. PubMed ID: 1296106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of compound-specific acceptable daily intakes for 11 mutagenic carcinogens used in pharmaceutical synthesis.
    Ellis P; Kenyon M; Dobo K
    Regul Toxicol Pharmacol; 2013 Mar; 65(2):201-13. PubMed ID: 23228434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative correlation of mutagenic and carcinogenic potencies for heterocyclic amines from cooked foods and additional aromatic amines.
    Hatch FT; Knize MG; Moore DH; Felton JS
    Mutat Res; 1992 Jun; 271(3):269-87. PubMed ID: 1378200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
    McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
    Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinyl carbamate epoxide, a major strong electrophilic, mutagenic and carcinogenic metabolite of vinyl carbamate and ethyl carbamate (urethane).
    Park KK; Liem A; Stewart BC; Miller JA
    Carcinogenesis; 1993 Mar; 14(3):441-50. PubMed ID: 8453720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lack of correspondence between carcinogenic and mutagenic effects of aminoazo dyes in suckling mice].
    Kaledin VI; Ronichevskaia GM; Zvereva LN
    Dokl Akad Nauk; 1994 Apr; 335(6):810-2. PubMed ID: 8025554
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemistry and biological activity of volatile and nonvolatile mutagenic compounds from cooked food.
    Overvik E; Berg I; Kleman M; Gustafsson JA
    IARC Sci Publ; 1990; (104):408-14. PubMed ID: 2228140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.